Time BioVentures is a full-spectrum healthcare and life sciences venture capital firm based in Southern California. We finance brilliant entrepreneurs with game-changing healthcare technologies to give patients more of life’s most valuable asset: time. Healthcare Venture Capital | Healthcare In
Investment Type: Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 15.07.2026 | AdvanCell ... | advancell.com.au | $457.55M | Australia |
Mentions in press and media 19
| Date | Title | Description |
| 16.07.2026 | AdvanCell Closes $315 Million Series D | BOSTON, MA, AdvanCell, a clinical-stage radiopharmaceutical company, announced the closing of an oversubscribed and upsized $315 million Series D financing. >> Click here for more funding data on AdvanCell >> To export AdvanCel... |
| 15.07.2026 | AdvanCell Closes US $315M in Series D Funding | AdvanCell, a Boston, MA- and Brisbane, Australia-based clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, raised US $315M Series D in funding. The round was led by Ally Bridge Group and Alpha Wave, al... |
| 23.06.2025 | Commons Clinic: $26 Million Series B Raised For Wholebody Multi-Specialty Care Platform | Commons Clinic announced a $26 million Series B financing, bringing the total funding to over $60 million. The funding round was led by RA Capital, with participation from Floating Point, SteelSky Ventures, Time BioVentures, Courtside Ventu... |
| 13.06.2025 | Commons Clinic Secures $26M to Revolutionize Preventative Healthcare | In a world where healthcare often feels fragmented, Commons Clinic is stitching together a cohesive fabric of care. The Los Angeles-based company recently secured $26 million in Series B funding, pushing its total capital to over $60 millio... |
| 12.06.2025 | Commons Clinic Secures $26M to Launch “Wholebody” Preventative Care Program | What You Should Know: – Commons Clinic today announced a $26M Series B financing, bringing its total funding to over $60M led by RA Capital, with participation from Floating Point, SteelSky Ventures, Time BioVentures, Courtside Ventures, an... |
| 26.03.2024 | Brightside Health Secures $33M to Expand Access to Mental Healthcare | What You Should Know: – Brightside Health, a teletherapy provider for depression, anxiety, and other mood disorders, raises $33M in Series C funding led by S32. – The funding round, which included participation from existing investors along... |
| 12.12.2022 | Kling Biotherapeutics Appoints Michael Koslowski, M.D. As Chief Executive Officer | AMSTERDAM, Dec. 12, 2022 /PRNewswire/ -- Kling Biotherapeutics, B.V., a clinical-stage company pioneering the discovery and development of novel antibody-based therapeutics, today announced the appointment of Michael Koslowski, M.D. as CEO.... |
| 31.10.2022 | Time BioVentures Launches $100M Fund | - |
| 27.10.2022 | Time BioVentures Launches Biotech Fund | Time BioVentures, a Los Angeles, CA-based early-stage life sciences venture firm, closed its first Fund, with $100m AUM. Backed by a roster of biotech and healthcare luminaries, Time BioVentures I, LP, will finance innovations in medicine. ... |
| - | dot.LA Summit: Advice from Powerhouse Women: Creating with Confidence | It’s no secret that female entrepreneurs receive less funding than their male counterparts–females only secured 2% of VC funding in 2021. The reality, however, is even more pronounced for women of color. But according to ComplYant founder S... |
Show more